ConCallIQ
Go Pro
APOLLOHOSP Healthcare 10 May 2025

Apollohosp Ltd — Q4 FY25

Apollo Hospitals delivered a strong Q4 FY25 with consolidated revenue of INR 5,592 crore (+13% YoY) and PAT of INR 390 crore (+54% YoY).

bullish high
Compare with...
Revenue ₹5,592 Cr +13%
EBITDA ₹770 Cr +20%
PAT ₹414 Cr +54%
EBITDA Margin 14%
Duration
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Bangladesh patient flow disruption

Continued impact from reduced Bangladesh patient inflows, expected to persist through Q1 FY26, affecting hospital revenue and margins.

medium · management_commentary
R

Margin dilution from new hospital ramp-up

New hospitals in Gurgaon, Pune, Kolkata, and Hyderabad will incur initial losses, potentially compressing healthcare services margins by ~140 bps in FY26.

medium · management_commentary
R

Quick commerce competition in pharmacy

Rapid delivery platforms (10-minute) are gaining share in OTC/FMCG, though Apollo's 19-minute proposition and RX focus mitigate impact.

low · analyst_question
R

Keimed merger integration risks

The Keimed merger process is expected to take 15 months; integration challenges could delay synergy realization.

low · analyst_question